Charles R. Hay

Consultant in Haemostasis and Thrombosis
Manchester Royal Infirmary

Presentation(s):

• OC 30.1 - Emicizumab prophylaxis in people with severe haemophilia A without inhibitors: outcomes from the UK Haemophilia Centre Doctors' Organisation

  Monday, July 11, 2022
  10:45 AM – 11:00 AM